SA PRO
Free Account
Zymeworks Inc.ZYMENASDAQ
LOADING
|||
OverviewChartsNewsFundamentalsEarningsAnalysts

Analyst Sentiment

Analysts lean bullish — 90% recommend buying.

Consensus Rating
Buy
20 analysts·High coverage
90%
Rating Distribution
Strong Buy
00%
Buy
1890%
Hold
210%
Sell
00%
Strong Sell
00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 57% higher.

Bear Case
$26.00
+18%
Consensus
$34.67
+57%
Bull Case
$40.00
+82%
Price Range20 analysts
Low
Consensus
High
$26.00
$40.00
Current Target
Current Price
$22.02
Upside to Target
$12.65

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$0.62(9 analysts)
Actual
Estimate
Range (Low–High)
Stock Alarm Pro
Forward Growth Estimates (YoY)
FY2027
Rev-23.44%
EPS—
FY2028
Rev+11.87%
EPS—
FY2029
Rev+55.02%
EPS—

Earnings Surprises

Beat rate:58%(7/12 quarters)
Avg surprise:-252.9%
Beat
Miss
Inline
Estimate
Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Dec 17, 2025Truist Financial
Zymeworks initiated with a Buy at Truist
Target:$40.00
+54.7%from $25.85
Dec 12, 2025Wells Fargo
Zymeworks upgraded to Overweight from Equal Weight at Wells Fargo
Target:$33.00
+32.4%from $24.93
Dec 3, 2025JMP Securities
Zymeworks initiated with an Outperform at Citizens JMP
Target:$32.00
+27.5%from $25.10
Nov 19, 2025Wells Fargo
Zymeworks (ZYME) PT Raised to $25 at Wells Fargo
Target:$25.00
+8.7%from $22.99
Nov 19, 2025Stifel Nicolaus
Zymeworks (ZYME) PT Raised to $40 at Stifel
Target:$40.00
+74.0%from $22.99
Nov 17, 2025Leerink Partners
Zymeworks price target raised to $37 from $24 at Leerink
Target:$37.00
+54.8%from $23.90
Oct 14, 2025H.C. Wainwright
Zymeworks upgraded to Buy from Neutral at H.C. Wainwright
Target:$26.00
+43.6%from $18.11
Nov 21, 2024Leerink Partners
Zymeworks (ZYME) PT Raised to $26 at Leerink Partners
Target:$26.00
+90.1%from $13.68
Nov 1, 2024Wells Fargo
Wells Fargo Downgrades Zymeworks (ZYME) to Equal Weight
Target:$12.00
-9.6%from $13.28
Oct 28, 2024Stifel Nicolaus
Zymeworks (ZYME) PT Raised to $28 at Stifel
Target:$28.00
+113.6%from $13.11
Sep 25, 2024H.C. Wainwright
Zymeworks price target raised to $12 from $10 at H.C. Wainwright
Target:$12.00
-4.0%from $12.50
Sep 18, 2024H.C. Wainwright
H.C. Wainwright Reiterates Neutral Rating on Zymeworks (ZYME)
Target:$10.00
-18.7%from $12.30
Sep 10, 2024Stifel Nicolaus
Stifel Reiterates Buy Rating on Zymeworks (ZYME)
Target:$21.00
+78.7%from $11.75
Dec 19, 2022Jefferies
Zymeworks upgraded to Buy from Hold at Jefferies
Target:$11.00
+62.0%from $6.79
Nov 1, 2022H.C. Wainwright
H.C. Wainwright downgrades Zymeworks on Jazz opt-out possibility
Target:$8.00
+9.7%from $7.29
Sep 20, 2021H.C. Wainwright
Analysts Offer Insights on Healthcare Companies: Seagen (NASDAQ: SGEN), Genmab (NASDAQ: GMAB) and Zymeworks (NYSE: ZYME)
Target:$44.00
+33.1%from $33.07

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance